Fernandez-Enright, Francesca E.

Top Publications

Year	Title
2012	Novel olanzapine analogues presenting a reduced H1 receptor affinity and retained 5HT2A/D2 binding affinity ratio Published in BMC Pharmacology
2012	Structural contributions of antipsychotic drugs to their therapeutic profiles and metabolic side effects Published in Journal of Neurochemistry

Selected Publications

Journal Article

Year	Title
2019	Perinatal exposure to fluoxetine increases anxiety- and depressive-like behaviours and alters glutamatergic markers in the prefrontal cortex and hippocampus of male adolescent rats: A comparison between Sprague-Dawley rats and the Wistar-Kyoto rat model of depression Published In Journal of Psychopharmacology Volume 33 Pages 230 - 243 ISSN 0269-8811 Altmetric
2018	Effects of common GRM5 genetic variants on cognition, hippocampal volume and mGluR5 protein levels in schizophrenia Published In Brain Imaging and Behavior: an international journal Volume 12 Pages 509 - 517 ISSN 1931-7557 Altmetric
2018	Perinatal administration of phencyclidine alters expression of Lingo-1 signaling pathway proteins in the prefrontal cortex of juvenile and adult rats Published In Neuronal Signaling Volume Online First
2018	Stress induced cortisol release and schizotypy Published In Psychoneuroendocrinology Volume 89 Pages 209 - 215 ISSN 0306-4530 Altmetric
2017	Alterations of ubiquitin related proteins in the pathology and development of schizophrenia: Evidence from human and animal studies Published In Journal of Psychiatric Research Volume 90 Pages 31 - 39 ISSN 0022-3956 Altmetric
2017	Effects of GRASP variation on memory in psychiatrically healthy individuals and cognitive dysfunction in schizophrenics Published In Gene Reports Volume 6 Pages 121 - 127 Altmetric
2017	Shifting towards a model of mGluR5 dysregulation in schizophrenia: consequences for future schizophrenia treatment Published In Neuropharmacology Volume 115 Pages 73 - 91 ISSN 0028-3908 Altmetric
2016	Genetic consideration of schizotypal traits: a review Published In Frontiers in Psychology Volume 15 Pages 1769-1 - 1769-19 ISSN 1664-1078 Altmetric
2016	Lingo-1: a novel target in therapy for Alzheimer's disease? Published In Neural Regeneration Research Volume 11 Pages 88 - 89 Altmetric
2016	Molecular evidence of synaptic pathology in CA1 in schizophrenia Published In Biological Psychiatry Volume 79 Pages 66S - 66S ISSN 0006-3223 Altmetric
2016	Molecular evidence of synaptic pathology in the CA1 region in schizophrenia Published In NPJ Schizophrenia Volume 2 Pages 16022-1 - 16022-8
2016	Neurodevelopmental expression profile of dimeric and monomeric group 1 mGluRs: relevance to schizophrenia pathogenesis and treatment Published In Scientific Reports Volume 6 Pages 34391-1 - 34391-10 ISSN 2045-2322 Altmetric
2016	Possibility of a sex-specific role for a genetic variant in FRMPD4 in schizophrenia, but not cognitive function Published In NeuroReport Volume 27 Pages 33 - 38 ISSN 0959-4965 Altmetric
2016	The Neurodevelopmental Profile of Group 1 Metabotropic Glutamate Receptors: Implications for Novel Therapeutics Published In International Journal of Neuropsychopharmacology Volume 19 Pages 78 - 79 ISSN 1461-1457 Altmetric
2015	A decade from discovery to therapy: Lingo-1, the dark horse in neurological and psychiatric disorders Published In Neuroscience and Biobehavioral Reviews Volume 56 Pages 97 - 114 ISSN 0149-7634 Altmetric
2015	Alterations of mGluR5 and its endogenous regulators Norbin, Tamalin and Preso1 in schizophrenia: towards a model of mGluR5 dysregulation Published In Acta Neuropathologica Volume 130 Pages 119 - 129 ISSN 0001-6322 Altmetric
2015	Alterations of p75 neurotrophin receptor and Myelin transcription factor 1 in the hippocampus of perinatal phencyclidine treated rats Published In Progress in Neuro-Psychopharmacology and Biological Psychiatry Volume 63 Pages 91 - 97 ISSN 0278-5846 Altmetric
2015	Bardoxolone methyl prevents high-fat diet-induced alterations in prefrontal cortex signalling molecules involved in recognition memory Published In Progress in Neuro-Psychopharmacology and Biological Psychiatry Volume 59 Pages 68 - 75 ISSN 0278-5846 Altmetric
2015	Genetic Variation in GRM5 is Associated with Cognition, Hippocampal Volume and Schizophrenia Published In Neuropsychopharmacology Volume 40 Pages S374 - S374 ISSN 0893-133X
2015	Genetic variants in Nogo receptor signaling pathways may be associated with early life adversity in schizophrenia susceptibility Published In BBA Clinical Volume 3 Pages 36 - 43 Altmetric
2015	Metabotropic glutamate receptor 5, and its trafficking molecules Norbin and Tamalin, are increased in the CA1 hippocampal region of subjects with schizophrenia Published In Schizophrenia Research Volume 166 Pages 212 - 218 ISSN 0920-9964 Altmetric
2015	NMDA receptor antagonism by phencyclidine reduces NWASP and WAVE1 protein expression and reduces levels of myelination markers in the prefrontal cortex of rats Published In Journal of Pharmaceutics & Pharmacology Volume 3 Pages 1 - 8
2014	Investigation of genetic variants in ubiquitin enzyme genes involved in the modulation of neurodevelopmental processes: a role in schizophrenia susceptibility? Published In Genetical Research Volume 96 Pages e15-1 - e15-9 ISSN 0016-6723 Altmetric
2014	Metabotropic glutamate receptor mGluR2/3 and mGluR5 binding in the anterior cingulate cortex in psychotic and nonpsychotic depression, bipolar disorder and schizophrenia: implications for novel mGluR-based therapeutics Published In Journal of Psychiatry and Neuroscience Volume 39 Pages 407 - 416 ISSN 0702-8466 Altmetric
2014	Novel implications of Lingo-1 and its signaling partners in schizophrenia Published In Translational Psychiatry Volume 4 Pages e348-1 - e348-8 ISSN 2158-3188 Altmetric
2014	Novel implications of lingo-1 signaling in the post-mortem schizophrenia brain Published In Biological Psychiatry Volume 75 Pages 186S - 186S ISSN 0006-3223 Altmetric
2013	Association of a GRIA3 gene polymorphism with migraine in an Australian case-control cohort Published In Headache Volume 53 Pages 1245 - 1249 ISSN 0017-8748 Altmetric
2013	In vivo pharmacological evaluations of novel olanzapine analogues in rats: a potential new avenue for the treatment of schizophrenia Published In PLoS One Volume 8 Pages e80979-1 - e80979-10 ISSN 1932-6203 Altmetric
2013	Short-term effects of fish and fish oil consumption on total and high molecular weight adiponectin levels in overweight and obese adults Published In Metabolism: clinical and experimental Volume 62 Pages 651 - 660 ISSN 0026-0495 Altmetric
2012	Genetic modulation of the long-term effects of cannabis on brain structure, function and symptomatology Published In Schizophrenia Research Volume 136 Pages S134 - S134 ISSN 0920-9964 Altmetric
2012	Novel olanzapine analogues presenting a reduced H1 receptor affinity and retained 5HT2A/D2 binding affinity ratio Published In BMC Pharmacology Volume 12 Pages 1 - 8 ISSN 1471-2210 Altmetric
2012	Structural contributions of antipsychotic drugs to their therapeutic profiles and metabolic side effects Published In Journal of Neurochemistry Volume 120 Pages 371 - 384 ISSN 0022-3042 Altmetric
2012	The dopamine b-hydroxylase 19 bp insertion/deletion polymorphism was associated with first-episode but not medicated chronic schizophrenia Published In Journal of Psychiatric Research Volume 46 Pages 733 - 737 ISSN 0022-3956 Altmetric
2012	Wip1 phosphatase positively modulates dendritic spine morphology and memory processes through the p38MAPK signaling pathway Published In Cell Adhesion and Migration Volume 6 Pages 333 - 343 ISSN 1933-6918 Altmetric
2011	Significant differences in gene expression of GABA receptors in peripheral blood leukocytes of migraineurs Published In Gene Volume 490 Pages 32 - 36 ISSN 0378-1119 Altmetric
2010	Genetics of menstrual migraine: the molecular evidence Published In Current Pain and Headache Reports Volume 14 Pages 389 - 395 ISSN 1531-3433 Altmetric
2010	Shorter telomere length in peripheral blood cells associated with migraine in women Published In Headache Volume 50 Pages 965 - 972 ISSN 0017-8748 Altmetric
2009	Association between migraine and a functional polymorphism at the DBH locus Published In Neurogenetics Volume 10 Pages 199 - 208 ISSN 1364-6745 Altmetric
2008	Investigation between the S377G3 GATA-4 polymorphism and migraine Published In The Open Neurology Journal Volume 2 Pages 35 - 38 ISSN 1874-205X Altmetric
2008	Investigation of gamma-aminobutyric acid (GABA) A receptors genes and migraine susceptibility Published In BMC Medical Genetics Volume 9 Pages 1 - 10 ISSN 1471-2350 Altmetric
2007	A Pharmacogenomic Evaluation of Migraine Therapy Published In Expert Opinion on Pharmacotherapy Volume 8 Pages 1821 - 1835 ISSN 1465-6566 Altmetric
2007	Allelic variation investigation of the estrogen receptor within an Australian multiple sclerosis population Published In Journal of the Neurological Sciences Volume 252 Pages 9 - 12 ISSN 0022-510X Altmetric
2007	Association analysis of chromosome 1 migraine candidate genes Published In BMC Medical Genetics Volume 8 Pages 1 - 8 ISSN 1471-2350 Altmetric
2007	Association study of a functional variant in intron 8 of the dopamine transporter gene and migraine susceptibility Published In European Journal of Neurology Volume 14 Pages 706 - 707 ISSN 1351-5101 Altmetric
2007	Gene expression studies in multiple sclerosis Published In Current Genomics Volume 8 Pages 181 - 189 ISSN 1389-2029 Altmetric
2007	Pharmacogenetics of migraine: genetic variants and their potential role in migraine therapy Published In Pharmacogenomics Volume 8 Pages 609 - 622 ISSN 1462-2416 Altmetric
2007	The search for migraine genes: an overview of current knowledge Published In Cellular and Molecular Life Sciences Volume 64 Pages 331 - 344 ISSN 1420-9071 Altmetric

Chapter

Year	Title
2007	The Genetics of Migraine Published In Migraine Disorders Research Trends Publisher Nova Science Publishers Inc. Pages 5 - 34

Conference Paper

Year	Title
2015	Association of a genetic variant in FRMPD4, encoding for the multi-scaffolding protein Preso1, with schizophrenia and cognition Published In Australian Society for Medical Research NSW Scientific Meeting
2015	Association of novel genetic variants in GRM5 with schizophrenia, cognition and hippocampal volume Published In Biological Psychiatry Australia Meeting
2015	Bardoxolone methyl: a potential therapeutic for the prevention of anti-psychotic drug-induced obesity? Published In Proceedings of 22nd Multidisciplinary ISBS International Neuroscience and Biological Psychiatry "Stress and Behavior" Conference Pages 22 - 22
2015	The dark triad of personality traits, diurnal cortisol variations and sleep-wake cycles Published In Conference Abstract: ASP2015 - 25th Annual Conference of the Australasian Society for Psychophysiology Altmetric
2014	Alterations of mGluR5 and mGluR5 signaling partners in schizophrenia Published In Abstracts for 2014 Society for Neuroscience Annual Meeting Page p. Online: Poster#: 706.09 / V4
2014	Effects of pharmacological blockade of Lingo - 1 signaling pathways in a phencyclidine rat model for schizophrenia Published In Abstracts for 2014 Society for Neuroscience Annual Meeting Page p. Online: Poster#: 525.03 / CC27
2014	Evidence of mGluR5 dysregulation in schizophrenia Published In Australian Neuroscience Society 34th Annual Meeting
2014	Novel implications of Lingo-1 signaling in the prefrontal cortex and hippocampus of perinatal phencyclidine treated rats in a neurodevelopmental model of schizophrenia Published In Presentation Abstract of the Society of Biological Psychiatry 69th Annual Scientific Meeting Page p. Online
2014	Novel implications of Lingo-1 signaling in the prefrontal cortex of perinatal phencyclidine treated rats in a neurodevelopmental model of schizophrenia Published In Abstract of 9th FENS Forum of Neuroscience Page p. Online- poster no. C114
2013	An analysis of metabotropic glutamate receptors 2/3 and 5 in schizophrenia, major depression and bipolar disorder from the stanley neuropathology consortium Published In 33rd Meeting of the Australian Neuroscience Society: Program, Abstracts & List of Registrants Pages 49 - 49
2013	Expression of proteins within the nogo receptor complex are altered in the dorsolateral prefrontal cortex in schizophrenia Published In 33rd Meeting of the Australian Neuroscience Society: Program, Abstracts & List of Registrants Pages 49 - 49
2013	Novel implications of Lingo-1 and its signalling partners in the Dorsolateral prefrontal cortex in schizophrenia Published In The 3rd Annual Biological Psychiatry Australia Scientific Meeting Pages 23 - 23
2012	Proteogenomic analyses of Lingo-1 and the Nogo receptor in schizophrenia Published In The 32nd Meeting of the Australian Neuroscience Society: Program, Abstracts & List of Registrants Pages 41 - 41

Investigator On

Year	Title
2017 - 2023	Does Omega-3 Supplementation Attenuate Aggressive Behaviour: A Multi-Centre Randomised Controlled Trial of a Broadly Disseminable Strategy Awarded by: National Health and Medical Research Council (NHMRC) Funding Scheme: Partnership Projects
2012 - 2016	Schizophrenia: reversal of antipsychotic drug-induced obesity and its related metabolic disorders Awarded by: National Health and Medical Research Council (NHMRC) Funding Scheme: Project Grant
2014	SR-LAB ABS System Awarded by: National Health and Medical Research Council (NHMRC) Funding Scheme: Equipment Grant
2013 - 2014	Investigation of anti-Lingo-1 as an emergent actor in the therapy for schizophrenia Awarded by: Schizophrenia Research Institute Funding Scheme: Grant in Aid
2011	Vulnerability markers in the association between cannabis and schizophrenia Awarded by: National Health and Medical Research Council (NHMRC) Funding Scheme: Project Grant
2010 - 2011	Prevention and early diagnosis of Alzheimer's disease: New models of detection using gene expression profiling in a case-control elderly population in the Illawarra region Awarded by: IRT Research Foundation Funding Scheme: Grant
2010	Precellys 24 tissue homogenizer and digital microplate shaker Awarded by: National Health and Medical Research Council (NHMRC) Funding Scheme: Equipment Grant
2008	The Development vitam D model (DVD) as an animal model for schizophrenia Awarded by: National Health and Medical Research Council (NHMRC) Funding Scheme: Project Grant

Top Publications

Year	Title
2012	Novel olanzapine analogues presenting a reduced H1 receptor affinity and retained 5HT2A/D2 binding affinity ratio Published in BMC Pharmacology
2012	Structural contributions of antipsychotic drugs to their therapeutic profiles and metabolic side effects Published in Journal of Neurochemistry

Selected Publications

Journal Article

Year	Title
2019	Perinatal exposure to fluoxetine increases anxiety- and depressive-like behaviours and alters glutamatergic markers in the prefrontal cortex and hippocampus of male adolescent rats: A comparison between Sprague-Dawley rats and the Wistar-Kyoto rat model of depression Published In Journal of Psychopharmacology Volume 33 Pages 230 - 243 ISSN 0269-8811 Altmetric
2018	Effects of common GRM5 genetic variants on cognition, hippocampal volume and mGluR5 protein levels in schizophrenia Published In Brain Imaging and Behavior: an international journal Volume 12 Pages 509 - 517 ISSN 1931-7557 Altmetric
2018	Perinatal administration of phencyclidine alters expression of Lingo-1 signaling pathway proteins in the prefrontal cortex of juvenile and adult rats Published In Neuronal Signaling Volume Online First
2018	Stress induced cortisol release and schizotypy Published In Psychoneuroendocrinology Volume 89 Pages 209 - 215 ISSN 0306-4530 Altmetric
2017	Alterations of ubiquitin related proteins in the pathology and development of schizophrenia: Evidence from human and animal studies Published In Journal of Psychiatric Research Volume 90 Pages 31 - 39 ISSN 0022-3956 Altmetric
2017	Effects of GRASP variation on memory in psychiatrically healthy individuals and cognitive dysfunction in schizophrenics Published In Gene Reports Volume 6 Pages 121 - 127 Altmetric
2017	Shifting towards a model of mGluR5 dysregulation in schizophrenia: consequences for future schizophrenia treatment Published In Neuropharmacology Volume 115 Pages 73 - 91 ISSN 0028-3908 Altmetric
2016	Genetic consideration of schizotypal traits: a review Published In Frontiers in Psychology Volume 15 Pages 1769-1 - 1769-19 ISSN 1664-1078 Altmetric
2016	Lingo-1: a novel target in therapy for Alzheimer's disease? Published In Neural Regeneration Research Volume 11 Pages 88 - 89 Altmetric
2016	Molecular evidence of synaptic pathology in CA1 in schizophrenia Published In Biological Psychiatry Volume 79 Pages 66S - 66S ISSN 0006-3223 Altmetric
2016	Molecular evidence of synaptic pathology in the CA1 region in schizophrenia Published In NPJ Schizophrenia Volume 2 Pages 16022-1 - 16022-8
2016	Neurodevelopmental expression profile of dimeric and monomeric group 1 mGluRs: relevance to schizophrenia pathogenesis and treatment Published In Scientific Reports Volume 6 Pages 34391-1 - 34391-10 ISSN 2045-2322 Altmetric
2016	Possibility of a sex-specific role for a genetic variant in FRMPD4 in schizophrenia, but not cognitive function Published In NeuroReport Volume 27 Pages 33 - 38 ISSN 0959-4965 Altmetric
2016	The Neurodevelopmental Profile of Group 1 Metabotropic Glutamate Receptors: Implications for Novel Therapeutics Published In International Journal of Neuropsychopharmacology Volume 19 Pages 78 - 79 ISSN 1461-1457 Altmetric
2015	A decade from discovery to therapy: Lingo-1, the dark horse in neurological and psychiatric disorders Published In Neuroscience and Biobehavioral Reviews Volume 56 Pages 97 - 114 ISSN 0149-7634 Altmetric
2015	Alterations of mGluR5 and its endogenous regulators Norbin, Tamalin and Preso1 in schizophrenia: towards a model of mGluR5 dysregulation Published In Acta Neuropathologica Volume 130 Pages 119 - 129 ISSN 0001-6322 Altmetric
2015	Alterations of p75 neurotrophin receptor and Myelin transcription factor 1 in the hippocampus of perinatal phencyclidine treated rats Published In Progress in Neuro-Psychopharmacology and Biological Psychiatry Volume 63 Pages 91 - 97 ISSN 0278-5846 Altmetric
2015	Bardoxolone methyl prevents high-fat diet-induced alterations in prefrontal cortex signalling molecules involved in recognition memory Published In Progress in Neuro-Psychopharmacology and Biological Psychiatry Volume 59 Pages 68 - 75 ISSN 0278-5846 Altmetric
2015	Genetic Variation in GRM5 is Associated with Cognition, Hippocampal Volume and Schizophrenia Published In Neuropsychopharmacology Volume 40 Pages S374 - S374 ISSN 0893-133X
2015	Genetic variants in Nogo receptor signaling pathways may be associated with early life adversity in schizophrenia susceptibility Published In BBA Clinical Volume 3 Pages 36 - 43 Altmetric
2015	Metabotropic glutamate receptor 5, and its trafficking molecules Norbin and Tamalin, are increased in the CA1 hippocampal region of subjects with schizophrenia Published In Schizophrenia Research Volume 166 Pages 212 - 218 ISSN 0920-9964 Altmetric
2015	NMDA receptor antagonism by phencyclidine reduces NWASP and WAVE1 protein expression and reduces levels of myelination markers in the prefrontal cortex of rats Published In Journal of Pharmaceutics & Pharmacology Volume 3 Pages 1 - 8
2014	Investigation of genetic variants in ubiquitin enzyme genes involved in the modulation of neurodevelopmental processes: a role in schizophrenia susceptibility? Published In Genetical Research Volume 96 Pages e15-1 - e15-9 ISSN 0016-6723 Altmetric
2014	Metabotropic glutamate receptor mGluR2/3 and mGluR5 binding in the anterior cingulate cortex in psychotic and nonpsychotic depression, bipolar disorder and schizophrenia: implications for novel mGluR-based therapeutics Published In Journal of Psychiatry and Neuroscience Volume 39 Pages 407 - 416 ISSN 0702-8466 Altmetric
2014	Novel implications of Lingo-1 and its signaling partners in schizophrenia Published In Translational Psychiatry Volume 4 Pages e348-1 - e348-8 ISSN 2158-3188 Altmetric
2014	Novel implications of lingo-1 signaling in the post-mortem schizophrenia brain Published In Biological Psychiatry Volume 75 Pages 186S - 186S ISSN 0006-3223 Altmetric
2013	Association of a GRIA3 gene polymorphism with migraine in an Australian case-control cohort Published In Headache Volume 53 Pages 1245 - 1249 ISSN 0017-8748 Altmetric
2013	In vivo pharmacological evaluations of novel olanzapine analogues in rats: a potential new avenue for the treatment of schizophrenia Published In PLoS One Volume 8 Pages e80979-1 - e80979-10 ISSN 1932-6203 Altmetric
2013	Short-term effects of fish and fish oil consumption on total and high molecular weight adiponectin levels in overweight and obese adults Published In Metabolism: clinical and experimental Volume 62 Pages 651 - 660 ISSN 0026-0495 Altmetric
2012	Genetic modulation of the long-term effects of cannabis on brain structure, function and symptomatology Published In Schizophrenia Research Volume 136 Pages S134 - S134 ISSN 0920-9964 Altmetric
2012	Novel olanzapine analogues presenting a reduced H1 receptor affinity and retained 5HT2A/D2 binding affinity ratio Published In BMC Pharmacology Volume 12 Pages 1 - 8 ISSN 1471-2210 Altmetric
2012	Structural contributions of antipsychotic drugs to their therapeutic profiles and metabolic side effects Published In Journal of Neurochemistry Volume 120 Pages 371 - 384 ISSN 0022-3042 Altmetric
2012	The dopamine b-hydroxylase 19 bp insertion/deletion polymorphism was associated with first-episode but not medicated chronic schizophrenia Published In Journal of Psychiatric Research Volume 46 Pages 733 - 737 ISSN 0022-3956 Altmetric
2012	Wip1 phosphatase positively modulates dendritic spine morphology and memory processes through the p38MAPK signaling pathway Published In Cell Adhesion and Migration Volume 6 Pages 333 - 343 ISSN 1933-6918 Altmetric
2011	Significant differences in gene expression of GABA receptors in peripheral blood leukocytes of migraineurs Published In Gene Volume 490 Pages 32 - 36 ISSN 0378-1119 Altmetric
2010	Genetics of menstrual migraine: the molecular evidence Published In Current Pain and Headache Reports Volume 14 Pages 389 - 395 ISSN 1531-3433 Altmetric
2010	Shorter telomere length in peripheral blood cells associated with migraine in women Published In Headache Volume 50 Pages 965 - 972 ISSN 0017-8748 Altmetric
2009	Association between migraine and a functional polymorphism at the DBH locus Published In Neurogenetics Volume 10 Pages 199 - 208 ISSN 1364-6745 Altmetric
2008	Investigation between the S377G3 GATA-4 polymorphism and migraine Published In The Open Neurology Journal Volume 2 Pages 35 - 38 ISSN 1874-205X Altmetric
2008	Investigation of gamma-aminobutyric acid (GABA) A receptors genes and migraine susceptibility Published In BMC Medical Genetics Volume 9 Pages 1 - 10 ISSN 1471-2350 Altmetric
2007	A Pharmacogenomic Evaluation of Migraine Therapy Published In Expert Opinion on Pharmacotherapy Volume 8 Pages 1821 - 1835 ISSN 1465-6566 Altmetric
2007	Allelic variation investigation of the estrogen receptor within an Australian multiple sclerosis population Published In Journal of the Neurological Sciences Volume 252 Pages 9 - 12 ISSN 0022-510X Altmetric
2007	Association analysis of chromosome 1 migraine candidate genes Published In BMC Medical Genetics Volume 8 Pages 1 - 8 ISSN 1471-2350 Altmetric
2007	Association study of a functional variant in intron 8 of the dopamine transporter gene and migraine susceptibility Published In European Journal of Neurology Volume 14 Pages 706 - 707 ISSN 1351-5101 Altmetric
2007	Gene expression studies in multiple sclerosis Published In Current Genomics Volume 8 Pages 181 - 189 ISSN 1389-2029 Altmetric
2007	Pharmacogenetics of migraine: genetic variants and their potential role in migraine therapy Published In Pharmacogenomics Volume 8 Pages 609 - 622 ISSN 1462-2416 Altmetric
2007	The search for migraine genes: an overview of current knowledge Published In Cellular and Molecular Life Sciences Volume 64 Pages 331 - 344 ISSN 1420-9071 Altmetric

Chapter

Year	Title
2007	The Genetics of Migraine Published In Migraine Disorders Research Trends Publisher Nova Science Publishers Inc. Pages 5 - 34

Conference Paper

Year	Title
2015	Association of a genetic variant in FRMPD4, encoding for the multi-scaffolding protein Preso1, with schizophrenia and cognition Published In Australian Society for Medical Research NSW Scientific Meeting
2015	Association of novel genetic variants in GRM5 with schizophrenia, cognition and hippocampal volume Published In Biological Psychiatry Australia Meeting
2015	Bardoxolone methyl: a potential therapeutic for the prevention of anti-psychotic drug-induced obesity? Published In Proceedings of 22nd Multidisciplinary ISBS International Neuroscience and Biological Psychiatry "Stress and Behavior" Conference Pages 22 - 22
2015	The dark triad of personality traits, diurnal cortisol variations and sleep-wake cycles Published In Conference Abstract: ASP2015 - 25th Annual Conference of the Australasian Society for Psychophysiology Altmetric
2014	Alterations of mGluR5 and mGluR5 signaling partners in schizophrenia Published In Abstracts for 2014 Society for Neuroscience Annual Meeting Page p. Online: Poster#: 706.09 / V4
2014	Effects of pharmacological blockade of Lingo - 1 signaling pathways in a phencyclidine rat model for schizophrenia Published In Abstracts for 2014 Society for Neuroscience Annual Meeting Page p. Online: Poster#: 525.03 / CC27
2014	Evidence of mGluR5 dysregulation in schizophrenia Published In Australian Neuroscience Society 34th Annual Meeting
2014	Novel implications of Lingo-1 signaling in the prefrontal cortex and hippocampus of perinatal phencyclidine treated rats in a neurodevelopmental model of schizophrenia Published In Presentation Abstract of the Society of Biological Psychiatry 69th Annual Scientific Meeting Page p. Online
2014	Novel implications of Lingo-1 signaling in the prefrontal cortex of perinatal phencyclidine treated rats in a neurodevelopmental model of schizophrenia Published In Abstract of 9th FENS Forum of Neuroscience Page p. Online- poster no. C114
2013	An analysis of metabotropic glutamate receptors 2/3 and 5 in schizophrenia, major depression and bipolar disorder from the stanley neuropathology consortium Published In 33rd Meeting of the Australian Neuroscience Society: Program, Abstracts & List of Registrants Pages 49 - 49
2013	Expression of proteins within the nogo receptor complex are altered in the dorsolateral prefrontal cortex in schizophrenia Published In 33rd Meeting of the Australian Neuroscience Society: Program, Abstracts & List of Registrants Pages 49 - 49
2013	Novel implications of Lingo-1 and its signalling partners in the Dorsolateral prefrontal cortex in schizophrenia Published In The 3rd Annual Biological Psychiatry Australia Scientific Meeting Pages 23 - 23
2012	Proteogenomic analyses of Lingo-1 and the Nogo receptor in schizophrenia Published In The 32nd Meeting of the Australian Neuroscience Society: Program, Abstracts & List of Registrants Pages 41 - 41

Investigator On

Year	Title
2017 - 2023	Does Omega-3 Supplementation Attenuate Aggressive Behaviour: A Multi-Centre Randomised Controlled Trial of a Broadly Disseminable Strategy Awarded by: National Health and Medical Research Council (NHMRC) Funding Scheme: Partnership Projects
2012 - 2016	Schizophrenia: reversal of antipsychotic drug-induced obesity and its related metabolic disorders Awarded by: National Health and Medical Research Council (NHMRC) Funding Scheme: Project Grant
2014	SR-LAB ABS System Awarded by: National Health and Medical Research Council (NHMRC) Funding Scheme: Equipment Grant
2013 - 2014	Investigation of anti-Lingo-1 as an emergent actor in the therapy for schizophrenia Awarded by: Schizophrenia Research Institute Funding Scheme: Grant in Aid
2011	Vulnerability markers in the association between cannabis and schizophrenia Awarded by: National Health and Medical Research Council (NHMRC) Funding Scheme: Project Grant
2010 - 2011	Prevention and early diagnosis of Alzheimer's disease: New models of detection using gene expression profiling in a case-control elderly population in the Illawarra region Awarded by: IRT Research Foundation Funding Scheme: Grant
2010	Precellys 24 tissue homogenizer and digital microplate shaker Awarded by: National Health and Medical Research Council (NHMRC) Funding Scheme: Equipment Grant
2008	The Development vitam D model (DVD) as an animal model for schizophrenia Awarded by: National Health and Medical Research Council (NHMRC) Funding Scheme: Project Grant

Fernandez-Enright, Francesca E.

Faculty Member

Overview

Top Publications

Publications

Selected Publications

Journal Article

Chapter

Conference Paper

Funding

Investigator On

Overview

Top Publications

Publications

Selected Publications

Journal Article

Chapter

Conference Paper

Funding

Investigator On

Visualisations